Benitec Biopharma Ltd (BNTC)

Benitec Biopharma (BNTC) Financial Statements


Benitec Biopharma Financial Overview

Benitec Biopharma's market cap is currently ―. The company's EPS TTM is $-9.866; its P/E ratio is -0.96; Benitec Biopharma is scheduled to report earnings on September 18, 2024, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 54.00K$ 14.00K$ 0.00$ 0.00$ 48.00K
Gross Profit$ 54.00K--$ -9.00K$ 48.00K
EBIT$ -4.40M$ -5.40M$ -5.08M$ -5.06M$ -3.27M
EBITDA-$ -5.30M$ -4.98M$ -4.99M$ -3.15M
Net Income Common Stockholders$ -4.40M$ -5.41M$ -5.09M$ -5.07M$ -3.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.60M$ 10.54M$ 16.53M$ 4.06M$ 8.63M
Total Assets$ 8.22M$ 11.90M$ 18.11M$ 5.97M$ 10.06M
Total Debt$ 623.00K$ 685.00K$ 749.00K$ 811.00K$ 867.00K
Net Debt$ -5.98M$ -9.85M$ -15.79M$ -3.25M$ -7.76M
Total Liabilities$ 3.51M$ 2.91M$ 3.50M$ 3.09M$ 2.54M
Stockholders Equity$ 4.71M$ 8.99M$ 14.61M$ 2.88M$ 7.52M
Cash Flow-
Free Cash Flow-$ -5.84M$ -4.04M$ -4.87M$ -3.42M
Operating Cash Flow$ -4.00M$ -5.84M$ -4.04M$ -4.86M$ -3.42M
Investing Cash Flow-$ 0.00$ 0.00$ -13.00K$ 0.00
Financing Cash Flow-$ 0.00$ 16.02M$ 0.00$ 0.00
Currency in USD

Benitec Biopharma Earnings and Revenue History

Benitec Biopharma Debt to Assets

Benitec Biopharma Cash Flow

Benitec Biopharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis